10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001019687-15-004147`
Period End Date	20150930
Filing Date	20151116
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	xbio-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 56 Cash Flow Statement 78

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.50B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	215.46M	shares	Point-in-time
Cash	`Cash`	$1.25M	USD	Point-in-time
Cash	`Cash`	$4.83M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	149.99M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	150.51M	shares	Point-in-time
Cash	`Cash`	$2.51M	USD	Point-in-time
Cash	`Cash`	$4.84M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	149.99M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$66.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	139.30M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$115.78K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$195.19K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$88.24K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.78M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$74.17K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$119.45K	USD	Point-in-time
Goodwill	`Goodwill`	$3.47M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.67M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.75M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$199.27K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$145.88K	USD	Point-in-time
Total assets	`Assets`	$16.32M	USD	Point-in-time
Total assets	`Assets`	$14.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$852.76K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.41M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.38M	USD	Point-in-time
Hybrid debt instrument	`HybridDebtInstrument`	$2.81M	USD	Point-in-time
Hybrid debt instrument	`HybridDebtInstrument`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$41.47K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$33.39K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$395.00K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$395.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.70M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$3.08M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$56.38K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$43.27K	USD	Point-in-time
Total liabilities	`Liabilities`	$9.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.84M	USD	Point-in-time
Common stock, $0.001 par value; 1,500,000,000 and 215,456,000 shares authorized as of September 30, 2015 and December 31, 2014, respectively; 150,513,011 and 149,985,476 shares issued as of September 30, 2015 and December 31, 2014, respectively; 139,824,817 and 139,297,282 shares outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$150.51K	USD	Point-in-time
Common stock, $0.001 par value; 1,500,000,000 and 215,456,000 shares authorized as of September 30, 2015 and December 31, 2014, respectively; 150,513,011 and 149,985,476 shares issued as of September 30, 2015 and December 31, 2014, respectively; 139,824,817 and 139,297,282 shares outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$149.99K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$94.56M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$90.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.62M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-84.50M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$575.68K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.48M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.25M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$816.32K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.50M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.91M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.41M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.98M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.72M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.20M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.13M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-8.71M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.11M	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-1.34M	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-1.34M	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	3 Qtrs
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Other expense	`OtherNonoperatingIncomeExpense`	$-72.88K	USD	1 Quarter
Other expense	`OtherNonoperatingIncomeExpense`	$-235.48K	USD	3 Qtrs
Other expense	`OtherNonoperatingIncomeExpense`	$-276.04K	USD	3 Qtrs
Other expense	`OtherNonoperatingIncomeExpense`	$-50.53K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$67.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$11.96K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$218.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.16K	USD	3 Qtrs
Interest expense	`InterestExpenseOther`	$3.57K	USD	3 Qtrs
Interest expense	`InterestExpenseOther`	$130.41K	USD	3 Qtrs
Interest expense	`InterestExpenseOther`	$127.90K	USD	1 Quarter
Interest expense	`InterestExpenseOther`	$1.20K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.30M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.75M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-73.86K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.88M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-10.00M	USD	3 Qtrs
Other comprehensive income (loss) from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-542.10K	USD	1 Quarter
Other comprehensive income (loss) from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-321.94K	USD	3 Qtrs
Other comprehensive income (loss) from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$5.11K	USD	1 Quarter
Other comprehensive income (loss) from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-18.46K	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.02M	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.32M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.20M	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.72M	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	3 Qtrs
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	139.62M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	136.05M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	134.75M	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	139.41M	shares	3 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.88M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-10.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$59.11K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$47.47K	USD	3 Qtrs
Amoritzation of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amoritzation of debt discount	`AmortizationOfDebtDiscountPremium`	$50.73K	USD	3 Qtrs
Non-cash interest expense	`InterestExpense`	$75.94K	USD	3 Qtrs
Non-cash interest expense	`InterestExpense`	-	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.29M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$246.26K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$678.51K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.06M	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-1.34M	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$-1.34M	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	$59.61K	USD	3 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	3 Qtrs
Hybrid debt instrument issuance costs	`DebtIssuanceCosts`	$-30.93K	USD	3 Qtrs
Hybrid debt instrument issuance costs	`DebtIssuanceCosts`	-	USD	3 Qtrs
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	$-1.07M	USD	3 Qtrs
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on disposal of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Fee paid on disposal of subsidiaries	`FeePaidOnDisposalOfSubsidiaries`	$-430.00K	USD	3 Qtrs
Fee paid on disposal of subsidiaries	`FeePaidOnDisposalOfSubsidiaries`	-	USD	3 Qtrs
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$44.74K	USD	3 Qtrs
Foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$-346.39K	USD	3 Qtrs
Other non-cash transactions	`OtherNoncashIncome`	$129.74K	USD	3 Qtrs
Other non-cash transactions	`OtherNoncashIncome`	-	USD	3 Qtrs
Other receivables, prepayments and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-50.46K	USD	3 Qtrs
Other receivables, prepayments and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$160.98K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.19M	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$585.68K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.02M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.19M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.66K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.01K	USD	3 Qtrs
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$5.49K	USD	3 Qtrs
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.25K	USD	3 Qtrs
Cash acquired from the acquisition	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Cash acquired from the acquisition	`CashAcquiredFromAcquisition`	$43.50K	USD	3 Qtrs
Cash transferred in connection with Hive Out Agreement	`CashDivestedFromDeconsolidation`	$43.50K	USD	3 Qtrs
Cash transferred in connection with Hive Out Agreement	`CashDivestedFromDeconsolidation`	-	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-40.52K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$4.58K	USD	3 Qtrs
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	-	USD	3 Qtrs
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	$3.10M	USD	3 Qtrs
Payments on debt	`RepaymentsOfDebt`	-	USD	3 Qtrs
Payments on debt	`RepaymentsOfDebt`	$100.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$101.93K	USD	3 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	$286.12K	USD	3 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.82M	USD	3 Qtrs
Effect of exchange rate change on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$238.44K	USD	3 Qtrs
Effect of exchange rate change on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-80.67K	USD	3 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-4.85K	USD	3 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-1.26M	USD	3 Qtrs
Cash at beginning of period	`Cash`	$1.25M	USD	Point-in-time
Cash at beginning of period	`Cash`	$4.83M	USD	Point-in-time
Cash at beginning of period	`Cash`	$2.51M	USD	Point-in-time
Cash at beginning of period	`Cash`	$4.84M	USD	Point-in-time
Cash at end of period	`Cash`	$1.25M	USD	Point-in-time
Cash at end of period	`Cash`	$4.83M	USD	Point-in-time
Cash at end of period	`Cash`	$2.51M	USD	Point-in-time
Cash at end of period	`Cash`	$4.84M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$592.00	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	-	USD	3 Qtrs
Equity consideration transferred in the acquisition	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	$3.75M	USD	3 Qtrs
Equity consideration transferred in the acquisition	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	-	USD	3 Qtrs
Repurchase and cancellation of common stock in disposal of subsidiaries	`StockRepurchasedAndRetiredDuringPeriodValue`	-	USD	3 Qtrs
Repurchase and cancellation of common stock in disposal of subsidiaries	`StockRepurchasedAndRetiredDuringPeriodValue`	$3.75M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.